Alkermes ALKS
NASDAQ ALKS
$45.43 -0.06 (-0.13%)
As of: Sep 9, 2026 · 1:23 PM EDT

Alkermes (ALKS) EV to FCF (2010 - 2026)

Alkermes' (ALKS) quarterly EV to FCF came in at 59.27 in Q2 2026, up 119.38% year-over-year from 27.02 in Q2 2025, and up 287.31% quarter-over-quarter from 31.64 in Q1 2026.

Analysis

Alkermes (ALKS) EV to FCF (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has reported EV to FCF for 17 consecutive years, with 59.27 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, EV to FCF rose 119.38% year-over-year to 59.27 in Q2 2026; TTM through Jun 2026 was 36.65, a 374.42% increase from a year earlier, with the FY2025 full-year figure at 7.32, down 24.15% from the prior year.
  • EV to FCF was 59.27 for Q2 2026 at Alkermes, up from 31.64 in the prior quarter.
  • Over five years, EV to FCF peaked at 300.39 in Q1 2024 and troughed at 410.5 in Q4 2022.
  • A 5-year average of 15.27 and a median of 24.74 in 2024 frame the typical range for EV to FCF.
  • The widest YoY moves for EV to FCF: up 687.64% in 2022, down 652.4% in 2022.
  • Over 5 years, EV to FCF stood at 410.5 in 2022, then surged by 110.42% to 42.77 in 2023, then tumbled by 49.36% to 21.66 in 2024, then slipped by 4.63% to 20.66 in 2025, then soared by 186.91% to 59.27 in 2026.
  • The last three EV to FCF figures came in at 59.27 (Q2 2026), 31.64 (Q1 2026), and 20.66 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 644.32 Bn 623.56 Bn 17.26 Bn
2 AbbVie 440.60 Bn 434.04 Bn 12.70 Bn
3 Merck 365.39 Bn 358.25 Bn 12.21 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn
5 Pfizer 159.22 Bn 147.52 Bn 10.94 Bn
6 Sanofi 52.48 Bn 45.10 Bn 10.79 Bn
7 Revolution Medicines 44.21 Bn 44.21 Bn -
8 Incyte 25.34 Bn 20.81 Bn 1.57 Bn
9 United Therapeutics 21.49 Bn 18.82 Bn 683.80 Mn
10 Alkermes 7.58 Bn 6.93 Bn 397.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 59.27
Mar 31, 2026 -31.64
Dec 31, 2025 20.66
Sep 30, 2025 45.54
Jun 30, 2025 27.02
Mar 31, 2025 51.40
Dec 31, 2024 21.66
Sep 30, 2024 49.36
Jun 30, 2024 22.47
Mar 31, 2024 300.39
Dec 31, 2023 42.77
Sep 30, 2023 44.34
Jun 30, 2023 21.27
Mar 31, 2023 -144.90
Dec 31, 2022 -410.50
Sep 30, 2022 -313.61
Jun 30, 2022 -351.44
Mar 31, 2022 271.13
Dec 31, 2021 144.47
Sep 30, 2021 56.77